載入...
BIMG-20. METABOLIC BIOMARKERS IN MICRODIALYSATE OF IDH-1 MUTANT TUMORS
Glioblastoma (GBM) is a common deadly malignant brain cancer of the central nervous system, with a median survival of 12–15 months. Scientific advancements are lacking in developing effective therapies for both primary GBM, as well as secondary GBMs, that typically originate as malignant transformat...
Na minha lista:
| 發表在: | Neurooncol Adv |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7994322/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab024.019 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|